Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC10H11F2N5O4 |
InChIKeyRQIYMUKKPIEAMB-JAWBFMPRSA-N |
CAS Registry103828-82-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | 01 Aug 1995 |